SAN FRANCISCO, United States (AP) An experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening but the anxiously awaited new data leaves unclear how much differenc.
A drug that offers a small benefit to Alzheimer's patients is making a big splash with doctors who treat the disease.The drug, a monoclonal antibody called lecanemab, dominated last week's Cli
Encore: Is lecanemab the Alzheimer s drug that will finally make a difference? wnmufm.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wnmufm.org Daily Mail and Mail on Sunday newspapers.
The experimental drug lecanemab was able to slow down Alzheimer's in a large study. Many researchers think the drug will become the first to help large numbers of patients.